These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6937939)

  • 41. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nuclear magnetic resonance study of the binding of tolbutamide and chlorpropamide to bovine serum albumin.
    Ueda H; Higashiyama K; Nagai T
    Chem Pharm Bull (Tokyo); 1980; 28(4):1016-21. PubMed ID: 7418103
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of heparin or salicylate infusion on serum protein binding and on concentrations of phenytoin in serum, brain and cerebrospinal fluid of rats.
    Chou RC; Levy G
    J Pharmacol Exp Ther; 1981 Oct; 219(1):42-8. PubMed ID: 7288614
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Drug interaction during therapy with tolbutamide. The influence of some commonly used drugs on plasma level and half life in diabetic out-patients (author's transl)].
    Kolenda KD; Grille W; Johnsen K
    Med Klin; 1979 Dec; 74(50):1914-22. PubMed ID: 542176
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Collateral effects of anti-ulcer therapy with carbenoxolone. General considerations. A clinical case].
    Frabetti F; Zardi V; Grappa P; Dattola L; Bellodi G
    Clin Ter; 1986 Jun; 117(6):455-62. PubMed ID: 3742966
    [No Abstract]   [Full Text] [Related]  

  • 46. Gastric and systemic effects of carbenoxolone and its derivative ISF 2715 in humans.
    Velo GP; Minuz P; Riela A; Brocco G; Degan M; Franco L; Cavallini G
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():361-5. PubMed ID: 2959078
    [No Abstract]   [Full Text] [Related]  

  • 47. Drug kinetics and alcohol ingestion.
    Sellers EM; Holloway MR
    Clin Pharmacokinet; 1978; 3(6):440-52. PubMed ID: 31257
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sulfamethizole-induced inhibition of diphenlhydantoin, tolbutamide, and warfarin metabolism.
    Lumholtz B; Siersbaek-Nielsen K; Skovsted L; Kampmann J; Hansen JM
    Clin Pharmacol Ther; 1975 Jun; 17(6):731-4. PubMed ID: 1139863
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of carbenoxolone sodium on gastric and duodenal mucus synthesis in mice.
    Dai S; Ogle CW; Cho CH
    Pharmacology; 1986; 33(1):58-60. PubMed ID: 2426720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Displacement of tolbutamide, glibencalmide and chlorpropamide from serum albumin by anionic drugs.
    Brown KF; Crooks MJ
    Biochem Pharmacol; 1976 May; 25(10):1175-8. PubMed ID: 820348
    [No Abstract]   [Full Text] [Related]  

  • 51. The effects of selected drugs on the in vitro protein binding of repaglinide in human plasma.
    Plum A; Müller LK; Jansen JA
    Methods Find Exp Clin Pharmacol; 2000 Apr; 22(3):139-43. PubMed ID: 10893694
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers.
    Uchida S; Yamada H; Li XD; Maruyama S; Ohmori Y; Oki T; Watanabe H; Umegaki K; Ohashi K; Yamada S
    J Clin Pharmacol; 2006 Nov; 46(11):1290-8. PubMed ID: 17050793
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of carbenoxolone on gastric prostaglandin E release and cytoprotection in the rat.
    Martin A; Gurrieri G; Sturniolo GC; Naccarato R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():409-10. PubMed ID: 6221623
    [No Abstract]   [Full Text] [Related]  

  • 54. Carbenoxolone and incorporation of (3H) glucosamine into gastric mucosa.
    Meek EM; Rhodes J; Mayberry JF
    Curr Med Res Opin; 1978; 5(8):645-7. PubMed ID: 710177
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of different oral anticoagulants on diphenylhydantoin (DPH) and tolbutamide metabolism.
    Skovsted L; Kristensen M; Hansen M; Siersbaek-Nielsen K
    Acta Med Scand; 1976; 199(6):513-5. PubMed ID: 59517
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro.
    Olsen H; Andersen A; Nordbø A; Kongsgaard UE; Børmer OP
    BMC Clin Pharmacol; 2004 Mar; 4():4. PubMed ID: 15046641
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies of phenytoin binding to human serum albumin by high-performance affinity chromatography.
    Chen J; Ohnmacht C; Hage DS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):137-45. PubMed ID: 15282104
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of magnesium hydroxide on the absorption and efficacy of tolbutamide and chlorpropamide.
    Kivistö KT; Neuvonen PJ
    Eur J Clin Pharmacol; 1992; 42(6):675-9. PubMed ID: 1623912
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug concentration in saliva.
    Mucklow JC; Bending MR; Kahn GC; Dollery CT
    Clin Pharmacol Ther; 1978 Nov; 24(5):563-70. PubMed ID: 29738
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction of phenylbutazone and tolbutamide in man.
    Szita M; Gachályi B; Tornyossy M; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):378-80. PubMed ID: 7450929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.